GREAT POINT PARTNERS LLC 13D and 13G filings for UroGen Pharma Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:47 pm Sale |
2024-09-30 | 13G | UroGen Pharma Ltd. URGN |
GREAT POINT PARTNERS LLC | 758,786 1.800% |
-1,861,759 (-71.04%) |
Filing |
| 2024-02-14 4:38 pm Unchanged |
2023-12-31 | 13G | UroGen Pharma Ltd. URGN |
GREAT POINT PARTNERS LLC | 2,620,545 8.490% |
0 (Unchanged) |
Filing |
| 2023-09-15 1:39 pm Purchase |
2023-09-08 | 13G | UroGen Pharma Ltd. URGN |
GREAT POINT PARTNERS LLC | 2,620,545 8.510% |
2,620,545 (New Position) |
Filing |